128 related articles for article (PubMed ID: 24559112)
1. Cysteine-rich positions outside the structural zinc motif of human papillomavirus E7 provide conformational modulation and suggest functional redox roles.
Chemes LB; Camporeale G; Sánchez IE; de Prat-Gay G; Alonso LG
Biochemistry; 2014 Mar; 53(10):1680-96. PubMed ID: 24559112
[TBL] [Abstract][Full Text] [Related]
2. Evolution of linear motifs within the papillomavirus E7 oncoprotein.
Chemes LB; Glavina J; Faivovich J; de Prat-Gay G; Sánchez IE
J Mol Biol; 2012 Sep; 422(3):336-46. PubMed ID: 22683353
[TBL] [Abstract][Full Text] [Related]
3. Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target.
Chemes LB; Sánchez IE; de Prat-Gay G
J Mol Biol; 2011 Sep; 412(2):267-84. PubMed ID: 21787785
[TBL] [Abstract][Full Text] [Related]
4. Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer.
Tzenov YR; Andrews PG; Voisey K; Popadiuk P; Xiong J; Popadiuk C; Kao KR
Mol Cancer Res; 2013 Jan; 11(1):19-30. PubMed ID: 23284001
[TBL] [Abstract][Full Text] [Related]
5. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
Hatterschide J; Brantly AC; Grace M; Munger K; White EA
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
[TBL] [Abstract][Full Text] [Related]
6. Degenerate cysteine patterns mediate two redox sensing mechanisms in the papillomavirus E7 oncoprotein.
Camporeale G; Lorenzo JR; Thomas MG; Salvatierra E; Borkosky SS; Risso MG; Sánchez IE; de Prat Gay G; Alonso LG
Redox Biol; 2017 Apr; 11():38-50. PubMed ID: 27863297
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induced by an antagonist peptide against HPV16 E7 in vitro and in vivo via restoration of p53.
Guo C; Liu K; Zheng Y; Luo H; Chen H; Huang L
Apoptosis; 2011 Jun; 16(6):606-18. PubMed ID: 21475994
[TBL] [Abstract][Full Text] [Related]
8. Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ.
Dreier K; Scheiden R; Lener B; Ehehalt D; Pircher H; Müller-Holzner E; Rostek U; Kaiser A; Fiedler M; Ressler S; Lechner S; Widschwendter A; Even J; Capesius C; Jansen-Dürr P; Zwerschke W
Virology; 2011 Jan; 409(1):54-68. PubMed ID: 20970819
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
[TBL] [Abstract][Full Text] [Related]
10. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
11. A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site.
Zine El Abidine A; Tomaić V; Bel Haj Rhouma R; Massimi P; Guizani I; Boubaker S; Ennaifer E; Banks L
Virology; 2017 Jan; 500():218-225. PubMed ID: 27829177
[TBL] [Abstract][Full Text] [Related]
12. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7.
Chemes LB; Sánchez IE; Smal C; de Prat-Gay G
FEBS J; 2010 Feb; 277(4):973-88. PubMed ID: 20088881
[TBL] [Abstract][Full Text] [Related]
13. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
[TBL] [Abstract][Full Text] [Related]
14. The heterogeneous structural behavior of E7 from HPV16 revealed by NMR spectroscopy.
Calçada EO; Felli IC; Hošek T; Pierattelli R
Chembiochem; 2013 Sep; 14(14):1876-82. PubMed ID: 23940009
[TBL] [Abstract][Full Text] [Related]
15. The Subcellular Localisation of the Human Papillomavirus (HPV) 16 E7 Protein in Cervical Cancer Cells and Its Perturbation by RNA Aptamers.
Cesur Ö; Nicol C; Groves H; Mankouri J; Blair GE; Stonehouse NJ
Viruses; 2015 Jun; 7(7):3443-61. PubMed ID: 26131956
[TBL] [Abstract][Full Text] [Related]
16. The human papillomavirus-16 E7 oncoprotein exerts antiapoptotic effects via its physical interaction with the actin-binding protein gelsolin.
Mileo AM; Abbruzzese C; Vico C; Bellacchio E; Matarrese P; Ascione B; Federico A; Della Bianca S; Mattarocci S; Malorni W; Paggi MG
Carcinogenesis; 2013 Oct; 34(10):2424-33. PubMed ID: 23729654
[TBL] [Abstract][Full Text] [Related]
17. The papillomavirus E7 proteins.
Roman A; Munger K
Virology; 2013 Oct; 445(1-2):138-68. PubMed ID: 23731972
[TBL] [Abstract][Full Text] [Related]
18. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
19. E7 oncoprotein of human papillomavirus: Structural dynamics and inhibitor screening study.
Aarthy M; Kumar D; Giri R; Singh SK
Gene; 2018 Jun; 658():159-177. PubMed ID: 29535023
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
